The United States has led the world in pharmaceutical innovation for decades by developing drugs that combat cancer, heart ...
Somehow Washington regards the industry, which has saved and improved tens of millions of lives, as a villain.
Between 2005 and 2015, nearly three-fourths of issued drug patents were for already existing drugs. A common argument in ...
Trade secrets entail significant risk, but can speed up the process of drug development. The great patent divide Drug development requires significant funding, but with a strong patent system and ...
On March 13, 2025, the Federal Circuit decided in Merck Sharp & Dohme B.V. v. Aurobindo Pharma USA, Inc. (No. 2023-2254) how ...
GLP-1 receptor agonists (GLP-1RAs) were initially approved for diabetes treatment (e.g., Ozempic®) but have revolutionized weight management ...
If left unchecked, the power of PBMs and their complex relationships within the American healthcare system could lead to higher drug costs and diminished returns.
The future of American drug innovation is threatened by US regulations that permit knockoff versions of new drugs to be sold ...
For decades, the United States has led the world in pharmaceutical innovation – developing drugs that combat cancer, heart ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback